Juliette F Spelman1,2, Stephanie Peglow1,2,3, Amy R Schwartz1,2, Lucille Burgo-Black1,2, Katelyn McNamara1, William C Becker1,2. 1. Departments of Internal Medicine, VA Connecticut Healthcare System West Haven, CT. 2. Department of Internal Medicine, Yale University School of Medicine, New Haven, CT. 3. Department of Psychiatry and Behavioral Medicine, Eastern Virginia Medical School, Norfolk, VA, USA.
Abstract
OBJECTIVE: Opioid prescribing for chronic pain significantly contributes to opioid overdose deaths in the United States. Naloxone as a take-home antidote to opioid overdose is underutilized and has not been evaluated in the high-risk chronic pain population. The objective was to increase overdose education and naloxone distribution (OEND) to high-risk patients on long-term opioid therapy for pain by utilizing group visits in primary care. DESIGN: Quality improvement intervention among two primary care clinics. SETTING: A large, academic facility within the Veterans Health Administration. SUBJECTS: Patients prescribed ≥100 mg morphine-equivalent daily dose or coprescribed opioids and benzodiazepines. METHODS: One clinic provided usual care with respect to OEND; another clinic encouraged attendance at an OEND group visit to all of its high-risk patients. RESULTS: We used attendance at group visits, prescriptions of naloxone issued, and patient satisfaction scores to evaluate this format of OEND. KEY RESULTS: Group OEND visits resulted in significantly more naloxone prescriptions than usual care. At these group visits, patients were engaged, valued the experience, and all requested a prescription for the naloxone kit. CONCLUSION: This quality improvement pilot study suggests that OEND group visits are a promising model of care. 2017 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
OBJECTIVE: Opioid prescribing for chronic pain significantly contributes to opioid overdose deaths in the United States. Naloxone as a take-home antidote to opioid overdose is underutilized and has not been evaluated in the high-risk chronic pain population. The objective was to increase overdose education and naloxone distribution (OEND) to high-risk patients on long-term opioid therapy for pain by utilizing group visits in primary care. DESIGN: Quality improvement intervention among two primary care clinics. SETTING: A large, academic facility within the Veterans Health Administration. SUBJECTS: Patients prescribed ≥100 mg morphine-equivalent daily dose or coprescribed opioids and benzodiazepines. METHODS: One clinic provided usual care with respect to OEND; another clinic encouraged attendance at an OEND group visit to all of its high-risk patients. RESULTS: We used attendance at group visits, prescriptions of naloxone issued, and patient satisfaction scores to evaluate this format of OEND. KEY RESULTS: Group OEND visits resulted in significantly more naloxone prescriptions than usual care. At these group visits, patients were engaged, valued the experience, and all requested a prescription for the naloxone kit. CONCLUSION: This quality improvement pilot study suggests that OEND group visits are a promising model of care. 2017 American Academy of Pain Medicine. This work is written by US Government employees and is in the public domain in the US.
Authors: Robin A Pollini; Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Ziming Xuan; Traci C Green; Alexander Y Walley Journal: J Am Pharm Assoc (2003) Date: 2022-03-19
Authors: Czarina N Behrends; Sarah Gutkind; Emily Winkelstein; Monique Wright; Jennifer Dolatshahi; Alice Welch; Denise Paone; Hillary V Kunins; Bruce R Schackman Journal: Subst Abus Date: 2021-10-19 Impact factor: 3.984
Authors: Allyson L Varley; Sunil Kripalani; Thomas Spain; Amanda S Mixon; Erin Acord; Russell Rothman; Heather M Limper Journal: Qual Manag Health Care Date: 2020 Jul/Sep Impact factor: 1.147
Authors: Tamara M Haegerich; Christopher M Jones; Pierre-Olivier Cote; Amber Robinson; Lindsey Ross Journal: Drug Alcohol Depend Date: 2019-09-19 Impact factor: 4.852